A 14-week, Randomized, Double-blind Placebo-controlled Study For Pregabalin In Subjects With Fibromyalgia
Phase of Trial: Phase III
Latest Information Update: 20 Feb 2017
At a glance
- Drugs Pregabalin (Primary)
- Indications Fibromyalgia; Musculoskeletal pain
- Focus Registrational; Therapeutic Use
- Sponsors Pfizer
- 19 Jan 2017 Status changed from active, no longer recruiting to completed.
- 13 Jan 2017 Planned End Date changed from 1 Dec 2016 to 1 Jan 2017.
- 21 Dec 2016 Planned End Date changed from 1 Nov 2016 to 1 Dec 2016.